Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 33 papers were listed this time. Here's a few in our areas of research interest:
Lee S, Baxter DC, Limone B, et al. Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States. J Med Econ. 2012 May 14. [Epub ahead of print] PubMed PMID: 22583065.
Smith-Palmer J, Fajardo-Montañana C, Pollock RF, et al. Long-term cost-effectiveness of insulin detemir versus NPH insulin in type 2 diabetes in Sweden. J Med Econ. 2012 May 8. [Epub ahead of print] PubMed PMID: 22563742.